Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment. - Wikidata - wikimedia - TriplyDB

Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment.

Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment.

http://www.wikidata.org/entity/Q35098763

about

Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II.

P2860

Q34451258-40231947-D78D-44E6-B0F1-DCBC17BFFA65 Q38378030-4AF90087-AB93-4CE9-A0F3-348A49D76C28

P2860

Still Struggling: characteristics of youth with OCD who are partial responders to medication treatment.

http://www.wikidata.org/entity/Q35098763

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Still Struggling: characterist ...... nders to medication treatment.

@ast

Still Struggling: characterist ...... nders to medication treatment.

@en

type

label

Still Struggling: characterist ...... nders to medication treatment.

@ast

Still Struggling: characterist ...... nders to medication treatment.

@en

prefLabel

Still Struggling: characterist ...... nders to medication treatment.

@ast

Still Struggling: characterist ...... nders to medication treatment.

@en

P1433

Q35098763-E114F404-5A8B-478F-B0A5-61B9A7370575

P1476

Q35098763-DCC70939-98EA-4341-94C9-F85E51066565

P2093

Q35098763-2C855716-1AC5-46D4-808D-9DA5ECB7379D

Q35098763-3F0C261E-111D-48C4-9643-F850405D24B1

Q35098763-47721C9B-ABD9-4208-AB58-2F3FE3703A49

Q35098763-59F23DE6-C433-4F3D-B371-3D8F1B832A1F

Q35098763-88B92EB1-9530-4375-9E30-4E0EFCD66200

Q35098763-90573063-BBC8-45FF-B14E-F0FD6E07959C

Q35098763-96E28C6E-3BC2-4CB3-8712-4942E8010304

Q35098763-98DDA290-BB40-477C-B222-0B8E7A66E092

Q35098763-9F7E426C-DA21-45FC-AC9C-57023D36FDDC

Q35098763-C6AA64F0-C826-4012-A37D-C2B7C2AC3F77

P2860

Q35098763-06222A16-AF4A-42F6-8E6A-7010EB59889C

Q35098763-0B3B5108-D82E-4E23-9747-B85AADB7F774

Q35098763-0CDF6348-8E2F-4882-A866-D5563ACA754D

Q35098763-0E9E569C-CEEE-4AA8-AED6-C98FCF4278BA

Q35098763-11826D62-5F1E-418B-B96A-BA68F3C62F48

Q35098763-17DC3B2E-C34B-498F-8D2A-60F69811975F

Q35098763-19128311-1C66-484F-ACC6-B7D5B3AE7648

Q35098763-1A362540-B423-4967-847F-D46F1CC69C87

Q35098763-1E86C639-E15F-4F39-896D-DE8D79275043

Q35098763-2E5B682D-7F77-49C6-905F-26D564BA9203

P2888

Q35098763-9E7D16AA-4595-45FB-BBA7-048A957CA0F3

P304

Q35098763-D0912E2D-BFE3-4072-817D-BEA83E0FF764

P31

Q35098763-18E23968-07CA-4516-B804-8E06FA6703D8

P356

Q35098763-319BAEC5-DED3-4956-B808-6367A24096CF

P433

Q35098763-58844AF3-CDE7-42E4-B1F1-A97E717C1A7B

P478

Q35098763-16EF3624-3304-463B-A7E1-0BF79CB23D93

P577

Q35098763-78FB742F-820D-466F-8AD2-579C9CF58B21

P5875

Q35098763-82C61B2F-9ACA-492B-B17C-D5F8E5954C4F

P698

Q35098763-D2B9D97D-DCB4-4330-B723-1D13537CDBC0

P932

Q35098763-11FEC0D2-EC14-4B44-9A56-AE3D4D69ABBB

P356

S10578-011-0227-4

P1433

Child Psychiatry and Human Development

P1476

Still Struggling: characterist ...... nders to medication treatment.

@en

P2093

A Chrisman

http://www.w3.org/2001/XMLSchema#string

A Garcia

http://www.w3.org/2001/XMLSchema#string

A Naeem

http://www.w3.org/2001/XMLSchema#string

D Fitzgerald

http://www.w3.org/2001/XMLSchema#string

J Freeman

http://www.w3.org/2001/XMLSchema#string

J March

http://www.w3.org/2001/XMLSchema#string

J Sapyta

http://www.w3.org/2001/XMLSchema#string

M Choate-Summers

http://www.w3.org/2001/XMLSchema#string

M Franklin

http://www.w3.org/2001/XMLSchema#string

M Khanna

http://www.w3.org/2001/XMLSchema#string

P2860

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections.

Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.

Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity.

The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization.

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.

Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases.

P2888

s10578-011-0227-4

P304

424-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10578-011-0227-4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51043164

http://www.w3.org/2001/XMLSchema#string

P698

21484416

http://www.w3.org/2001/XMLSchema#string

P932

3134148

http://www.w3.org/2001/XMLSchema#string